Interferon alpha-2b (IFNα-2b) is an important therapeutic product in the treatment of chronic Hepatitis C and hairy cell leukaemia; however, its downstream processing is hindered by the high cost of conventional purification strategies (Castro et al., 2020). The gene discussed is IFNA2; the disease is hairy cell leukemia.